March 2, 2026 · Form 4 insider transaction
O'Loughlin Steve bought 9,500 shares of CNS Pharmaceuticals, Inc., a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Each restricted stock unit represents a contingent right to receive one share of Company common stock.; Issued in connection with the reporting person's employment with the Company.; The restricted stock units set forth in the table vest as follows: 25% on the six-month anniversary of the transaction date, 25% on the twelve-month anniversary of the transaction date, and the remaining 50% in twelve quarterly installments thereafter, subject to the reporting person's continued employment on each vesting date.